BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30115766)

  • 21. THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.
    Parker LA; Gillies T
    Behav Neurosci; 1995 Feb; 109(1):71-8. PubMed ID: 7734082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/'Spice' constituent JWH-018 in mice.
    Hyatt WS; Fantegrossi WE
    Behav Pharmacol; 2014 Jun; 25(3):253-7. PubMed ID: 24625557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats.
    Schramm-Sapyta NL; Cha YM; Chaudhry S; Wilson WA; Swartzwelder HS; Kuhn CM
    Psychopharmacology (Berl); 2007 May; 191(4):867-77. PubMed ID: 17211649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.
    Panagis G; Vlachou S; Nomikos GG
    Curr Drug Abuse Rev; 2008 Nov; 1(3):350-74. PubMed ID: 19630731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents.
    Vlachou S; Nomikos GG; Stephens DN; Panagis G
    Behav Pharmacol; 2007 Jul; 18(4):311-9. PubMed ID: 17551324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased sensitivity to Δ
    Ponzoni L; Moretti M; Braida D; Zoli M; Clementi F; Viani P; Sala M; Gotti C
    Eur Neuropsychopharmacol; 2019 Apr; 29(4):566-576. PubMed ID: 30773388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dependence and Cytotoxicity of Components of Cannabis].
    Funada M; Tomiyama KI
    Yakugaku Zasshi; 2020; 140(2):205-214. PubMed ID: 32009044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.
    Abdel-Kader MS; Radwan MM; Metwaly AM; Eissa IH; Hazekamp A; ElSohly MA
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542886
    [No Abstract]   [Full Text] [Related]  

  • 29. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
    Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural and neurochemical effects of combined MDMA and THC administration in mice.
    Robledo P; Trigo JM; Panayi F; de la Torre R; Maldonado R
    Psychopharmacology (Berl); 2007 Dec; 195(2):255-64. PubMed ID: 17684733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of reinforcing and aversive effects of voluntary Δ
    Barrus DG; Lefever TW; Wiley JL
    Neuropharmacology; 2018 Jul; 137():133-140. PubMed ID: 29758385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats.
    Manwell LA; Mallet PE
    Psychopharmacology (Berl); 2015 May; 232(9):1655-65. PubMed ID: 25395060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditioned taste avoidance induced by Δ(9)-tetrahydrocannabinol in the Fischer (F344) and Lewis (LEW) rat strains.
    Wakeford AG; Riley AL
    Pharmacol Biochem Behav; 2014 Jan; 116():39-44. PubMed ID: 24239786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between cannabidiol and Δ
    Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis and exercise: Effects of Δ
    Hurel I; Muguruza C; Redon B; Marsicano G; Chaouloff F
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110117. PubMed ID: 32971218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress.
    Childs E; Lutz JA; de Wit H
    Drug Alcohol Depend; 2017 Aug; 177():136-144. PubMed ID: 28599212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
    Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adolescent exposure to delta-9-tetrahydrocannabinol and ethanol heightens sensitivity to fear stimuli.
    Smiley CE; Saleh HK; Nimchuk KE; Garcia-Keller C; Gass JT
    Behav Brain Res; 2021 Oct; 415():113517. PubMed ID: 34389427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.